vs
天弘科技（CLS）与COMMUNITY HEALTH SYSTEMS INC（CYH）财务数据对比。点击上方公司名可切换其他公司
天弘科技的季度营收约是COMMUNITY HEALTH SYSTEMS INC的1.3倍（$4.0B vs $3.1B），天弘科技净利率更高（5.2% vs 3.5%，领先1.7%），天弘科技同比增速更快（52.8% vs -4.8%），COMMUNITY HEALTH SYSTEMS INC自由现金流更多（$172.0M vs $137.9M），过去两年天弘科技的营收复合增速更高（35.4% vs -0.5%）
天弘科技（Celestica Inc.）是总部位于加拿大安大略省多伦多的跨国电子制造服务（EMS）企业，业务涵盖设计、生产制造、硬件平台搭建及供应链服务，目前在全球15个国家设有50个运营站点，为各行业客户提供专业的电子产业链相关解决方案。
社区卫生系统公司总部位于美国田纳西州富兰克林，是财富500强企业。按急症护理机构数量计算，该公司曾是美国最大的综合医院医疗服务提供商。2014年它旗下有约200家医院，到2021年机构数量缩减至约85家。
CLS vs CYH — 直观对比
营收规模更大
CLS
是对方的1.3倍
$3.1B
营收增速更快
CLS
高出57.6%
-4.8%
净利率更高
CLS
高出1.7%
3.5%
自由现金流更多
CYH
多$34.1M
$137.9M
两年增速更快
CLS
近两年复合增速
-0.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.0B | $3.1B |
| 净利润 | $212.3M | $110.0M |
| 毛利率 | 10.8% | 85.6% |
| 营业利润率 | 6723.5% | 14.5% |
| 净利率 | 5.2% | 3.5% |
| 营收同比 | 52.8% | -4.8% |
| 净利润同比 | 146.3% | 254.9% |
| 每股收益（稀释后） | $1.83 | $0.82 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLSCYH
| Q1 26 | $4.0B | — | ||
| Q4 25 | $3.7B | $3.1B | ||
| Q3 25 | $3.2B | $3.1B | ||
| Q2 25 | $2.9B | $3.1B | ||
| Q1 25 | $2.6B | $3.2B | ||
| Q4 24 | — | $3.3B | ||
| Q3 24 | $2.5B | $3.1B | ||
| Q2 24 | $2.4B | $3.1B |
净利润CLSCYH
| Q1 26 | $212.3M | — | ||
| Q4 25 | $267.5M | $110.0M | ||
| Q3 25 | $267.8M | $130.0M | ||
| Q2 25 | $211.0M | $282.0M | ||
| Q1 25 | $86.2M | $-13.0M | ||
| Q4 24 | — | $-71.0M | ||
| Q3 24 | $89.5M | $-391.0M | ||
| Q2 24 | $95.0M | $-13.0M |
毛利率CLSCYH
| Q1 26 | 10.8% | — | ||
| Q4 25 | 11.8% | 85.6% | ||
| Q3 25 | 13.0% | 85.1% | ||
| Q2 25 | 12.8% | 85.0% | ||
| Q1 25 | 10.3% | 84.5% | ||
| Q4 24 | — | 84.5% | ||
| Q3 24 | 10.4% | 84.8% | ||
| Q2 24 | 10.6% | 84.6% |
营业利润率CLSCYH
| Q1 26 | 6723.5% | — | ||
| Q4 25 | 8.6% | 14.5% | ||
| Q3 25 | 10.2% | 7.9% | ||
| Q2 25 | 9.4% | 16.3% | ||
| Q1 25 | 4.9% | 9.0% | ||
| Q4 24 | — | 8.5% | ||
| Q3 24 | 5.5% | -6.6% | ||
| Q2 24 | 5.6% | 7.6% |
净利率CLSCYH
| Q1 26 | 5.2% | — | ||
| Q4 25 | 7.3% | 3.5% | ||
| Q3 25 | 8.4% | 4.2% | ||
| Q2 25 | 7.3% | 9.0% | ||
| Q1 25 | 3.3% | -0.4% | ||
| Q4 24 | — | -2.2% | ||
| Q3 24 | 3.6% | -12.7% | ||
| Q2 24 | 4.0% | -0.4% |
每股收益（稀释后）CLSCYH
| Q1 26 | $1.83 | — | ||
| Q4 25 | $2.29 | $0.82 | ||
| Q3 25 | $2.31 | $0.96 | ||
| Q2 25 | $1.82 | $2.09 | ||
| Q1 25 | $0.74 | $-0.10 | ||
| Q4 24 | — | $-0.53 | ||
| Q3 24 | $0.75 | $-2.95 | ||
| Q2 24 | $0.80 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $378.0M | $260.0M |
| 总债务越低越好 | — | $10.4B |
| 股东权益账面价值 | $2.1B | $-1.4B |
| 总资产 | $8260.0B | $13.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLSCYH
| Q1 26 | $378.0M | — | ||
| Q4 25 | $595.6M | $260.0M | ||
| Q3 25 | $305.9M | $123.0M | ||
| Q2 25 | $313.8M | $456.0M | ||
| Q1 25 | $303.0M | $431.0M | ||
| Q4 24 | — | $37.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $39.0M |
总债务CLSCYH
| Q1 26 | — | — | ||
| Q4 25 | $750.5M | $10.4B | ||
| Q3 25 | $756.7M | — | ||
| Q2 25 | $848.6M | — | ||
| Q1 25 | $915.0M | — | ||
| Q4 24 | — | $11.5B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CLSCYH
| Q1 26 | $2.1B | — | ||
| Q4 25 | $2.2B | $-1.4B | ||
| Q3 25 | $2.0B | $-1.5B | ||
| Q2 25 | $1.8B | $-1.6B | ||
| Q1 25 | $1.6B | $-1.9B | ||
| Q4 24 | — | $-1.9B | ||
| Q3 24 | $1.8B | $-1.8B | ||
| Q2 24 | $1.8B | $-1.4B |
总资产CLSCYH
| Q1 26 | $8260.0B | — | ||
| Q4 25 | $7.2B | $13.2B | ||
| Q3 25 | $6.6B | $13.2B | ||
| Q2 25 | $6.2B | $13.6B | ||
| Q1 25 | $5.8B | $13.9B | ||
| Q4 24 | — | $14.1B | ||
| Q3 24 | — | $13.9B | ||
| Q2 24 | — | $14.4B |
负债/权益比CLSCYH
| Q1 26 | — | — | ||
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.48× | — | ||
| Q1 25 | 0.59× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $356.3M | $266.0M |
| 自由现金流经营现金流 - 资本支出 | $137.9M | $172.0M |
| 自由现金流率自由现金流/营收 | 3.4% | 5.5% |
| 资本支出强度资本支出/营收 | — | 3.0% |
| 现金转化率经营现金流/净利润 | 1.68× | 2.42× |
| 过去12个月自由现金流最近4个季度 | $502.6M | $208.0M |
8季度趋势，按日历期对齐
经营现金流CLSCYH
| Q1 26 | $356.3M | — | ||
| Q4 25 | $250.6M | $266.0M | ||
| Q3 25 | $126.2M | $69.0M | ||
| Q2 25 | $152.4M | $88.0M | ||
| Q1 25 | $130.3M | $120.0M | ||
| Q4 24 | — | $216.0M | ||
| Q3 24 | $122.8M | $67.0M | ||
| Q2 24 | $99.6M | $101.0M |
自由现金流CLSCYH
| Q1 26 | $137.9M | — | ||
| Q4 25 | $155.9M | $172.0M | ||
| Q3 25 | $88.9M | $4.0M | ||
| Q2 25 | $119.9M | $-3.0M | ||
| Q1 25 | $93.6M | $35.0M | ||
| Q4 24 | — | $107.0M | ||
| Q3 24 | $76.8M | $-3.0M | ||
| Q2 24 | $62.7M | $13.0M |
自由现金流率CLSCYH
| Q1 26 | 3.4% | — | ||
| Q4 25 | 4.3% | 5.5% | ||
| Q3 25 | 2.8% | 0.1% | ||
| Q2 25 | 4.1% | -0.1% | ||
| Q1 25 | 3.5% | 1.1% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 3.1% | -0.1% | ||
| Q2 24 | 2.6% | 0.4% |
资本支出强度CLSCYH
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 3.0% | ||
| Q3 25 | 1.2% | 2.1% | ||
| Q2 25 | 1.1% | 2.9% | ||
| Q1 25 | 1.4% | 2.7% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | 1.8% | 2.3% | ||
| Q2 24 | 1.5% | 2.8% |
现金转化率CLSCYH
| Q1 26 | 1.68× | — | ||
| Q4 25 | 0.94× | 2.42× | ||
| Q3 25 | 0.47× | 0.53× | ||
| Q2 25 | 0.72× | 0.31× | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLS
暂无分部数据
CYH
| Managed Care And Other Third Party Payors | $1.5B | 49% |
| Medicare Managed Care | $570.0M | 18% |
| Medicare | $512.0M | 16% |
| Medicaid | $464.0M | 15% |
| Self Pay Revenue | $34.0M | 1% |
